
Release date: 2024-07-08 12:08:46 Article From: Lucius Laos Recommended: 1045
As 2022 draws to a close, Lucius Pharmaceutical (Laos) Co., Ltd. ushered in the inspection and training of GMP professional teams organized by the Lao national government department.
What is GMP? The GMP workshop is a well-managed style workshop. "GMP" is the abbreviation of Good Manufacturing Practice in English, GMP means "Good Manufacturing Practice" or "Good Manufacturing Practice" in Chinese, and is an independent management system that pays special attention to the implementation of product quality and health safety in the production process. GMP workshop is more than just hardware construction. GMP is a set of mandatory standards applicable to pharmaceutical, food, cosmetics, and other industries, requiring enterprises to meet the health and quality requirements in accordance with relevant national laws and regulations in terms of raw materials, personnel, facilities and equipment, production process, packaging and transportation, quality control, etc., and form a set of operable operating specifications to help enterprises improve the sanitary environment of enterprises and find problems in the production process in a timely manner to improve. Briefly, GMP requires pharmaceutical, food, cosmetics, and other manufacturers to have good production equipment, reasonable production processes, perfect quality management, and strict testing systems to ensure that the quality of final products meets regulatory requirements.

Lucius Pharma received a team of GMP professionals from Laos
On the morning of November 10, 2022, the morning sun was bright and transparent, everything was happy, the fog had dissipated, and the rising sun of the east sun shone rays of sunlight, sprinkling the entire Lucius Park. The tense expressions of all Lucius employees were swept away by the morning breeze, and it seemed that the whole park was soothed by this beautiful morning and fresh air.
On this day, the Lao government departments have the Ministry of Health, the Ministry of the Interior, the Ministry of Environment, and other officials to form a strong leadership team to visit Lucius Pharmaceutical Park to guide the work, accompanied by the chairman, CEO and other investors of Lucius Pharmaceutical to guide and inspect the work.
The seminar was mainly organized by the Food and Drug Administration, a department directly under the Ministry of Health, and the main health officials who participated included Dr. Ben Su, Director of the Food and Drug Administration, Dr. Su Lisha, Deputy Director, Dr. Su Songben, Deputy Director, Dr. Da Zhang, Director of the Drug Division, and Director of the Drug Testing Center.

The moment the expert group inspected the Lucius workshop
The members of the expert group put on special clothes for the clean workshop and conducted a strict visit and inspection of the GMP production workshop of Lucius Pharmaceutical! The inspection training lasted for two days!

Participants receive a certificate of completion
During the two-day GMP expert group, the members of the GMP expert group conducted professional training and the most rigorous inspection of Lucius Pharmaceutical and issued a training certificate to each of the participating production personnel who participated in the training and research, so that Lucius Pharmaceutical Group obtained the GMP inspection and testing evaluation at the national level in Laos. And obtained the GMP certification certificate from the Ministry of Health of the People's Republic of China.

Lucius Pharmaceutical (Laos) Co., Ltd. GMP Certification
Our efforts of all Lucius people will eventually have results, our Lucius Pharmaceutical will also develop and grow over time, the original intention of Lucius Pharmaceutical has always remained the same, our goal is to become the world's first-class generic drug company, quality first is our purpose, and it is our original intention to let the people below the global poverty line out of the sea of suffering!
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed countries (extended to July 1, 2033), Laos has been legally permitted to produce ge···【more】
Recommended:219Release date: 2026-08-05
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos have gradually entered the view of Chinese cancer and chronic disease patients due ···【more】
Recommended:230Release date: 2026-08-04
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rapid growth in its generic pharmaceutical industry in recent years. Lucius Pharmac···【more】
Recommended:271Release date: 2026-07-31
Lucius Pharmaceutical is a modern pharmaceutical enterprise headquartered in Vientiane, the capital of Laos. The company was established in 2020, with its R&D and operational s···【more】
Recommended:203Release date: 2026-07-28
Lucius Pharmaceuticals Relocates from India to Laos: A Five-Year Development Journey of a Generic Drug CompanyRelocation Background and Strategic ShiftLucius Pharmaceuticals was fo···【more】
Recommended:305Release date: 2026-07-24
In recent years, Laos has gradually become a major global supply source for generic drugs, leveraging the WTO-granted patent exemption for least-developed countries. Among them, Lu···【more】
Recommended:242Release date: 2026-07-22
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020, with its headquarters located at No. 26, Thongmang Village···【more】
Recommended:258Release date: 2026-07-20
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was established in Vientiane, the capital of Laos, in 2020 and has been in operatio···【more】
Recommended:274Release date: 2026-07-17
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos' generic drug industry is rooted in unique international rule dividends. As a U···【more】
Recommended:380Release date: 2026-07-16
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease patients in China due to their significant price advantage. Leveraging the WTO pat···【more】
Recommended:229Release date: 2026-07-15
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulation adopts a centralized "one ministry, one department" management mod···【more】
Recommended:298Release date: 2026-07-14
Overview of Lao generic drug industryThe Lao generic drug industry started late but has developed rapidly in recent years. Relying on the WTO's patent waiver for least develope···【more】
Recommended:324Release date: 2026-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:924Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:865Release date: 2024-07-09
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic name: vibegron) is an oral, once-daily β3-adrenergic receptor agonist approved by ···【more】
Recommended:174Release date: 2026-08-06
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 previously untreated CLL/SLL patients aged 65 years and older, ibrutinib demonst···【more】
Recommended:186Release date: 2026-08-03
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the class of ALK inhibitors. Unlike traditional chemotherapy, it does not act by kill···【more】
Recommended:167Release date: 2026-07-30
Lucius Pharmaceuticals Quizartinib (Quizartinib) Has Been Launched(1) Quizartinib is an oral tablet. The recommended dose is once daily, one tablet per day (the specific dose is de···【more】
Recommended:196Release date: 2026-07-29
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies for DacomitinibRash and exfoliative skin reactions are highly characteristic adv···【more】
Recommended:207Release date: 2026-07-21
Lao PDR: Filgotinib Has Been LaunchedBefore initiating filgotinib treatment, strict screening for the following contraindications is mandatory; the presence of any one of these con···【more】
Recommended:198Release date: 2026-07-13
Lucius Pharmaceuticals' Pirtobrutinib Has Been LaunchedPirtobrutinib is an oral anticancer drug whose active ingredient is pirtobrutinib, belonging to the class of Bruton's···【more】
Recommended:227Release date: 2026-07-10
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagolix sodium (trade name LuciElag) for the treatment of moderate to severe pain associated with endometr···【more】
Recommended:250Release date: 2026-07-06
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strictly contraindicated in the following situations: ①hypersensitivity to bempedoic acid or any excipient···【more】
Recommended:218Release date: 2026-07-03
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended:254Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended:349Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended:685Release date: 2025-12-17

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643